表紙:深部脳刺激装置:医療機器のパイプライン評価
市場調査レポート
商品コード
347932

深部脳刺激装置:医療機器のパイプライン評価

Deep Brain Stimulators (DBS) - Medical Devices Pipeline Product Landscape, 2021

出版日: | 発行: GlobalData | ページ情報: 英文 131 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.31円
深部脳刺激装置:医療機器のパイプライン評価
出版日: 2021年11月15日
発行: GlobalData
ページ情報: 英文 131 Pages
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、深部脳刺激装置のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 深部脳刺激装置の概要

第3章 開発中の製品

  • 深部脳刺激装置 - パイプライン製品:開発段階別
  • 深部脳刺激装置 - パイプライン製品:地域別
  • 深部脳刺激装置 - パイプライン製品:規制別
  • 深部脳刺激装置 - パイプライン製品:承認予定日別
  • 深部脳刺激装置 - 進行中の臨床試験

第4章 深部脳刺激装置 - 開発中のパイプライン製品:企業別

  • 深部脳刺激装置企業 - パイプライン製品:開発段階別
  • 深部脳刺激装置 - パイプライン製品:開発段階別

第5章 深部脳刺激装置企業と製品の概要

  • Adaptive Neuromodulation GmbH
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Brainsway Ltd.
  • Cerene Biomedics, Inc
  • Children's Hospital Boston
  • Cleveland Medical Devices, Inc.
  • Clinatec
  • Deep Brain Innovations, LLC
  • Duke University
  • Functional Neuromodulation Inc.
  • Highland Instruments, Inc.
  • Massachusetts General Hospital
  • Mayo Clinic.
  • Medtronic plc
  • National Cheng-Kung University Hospital
  • NeuroPro Technologies, Inc.
  • NeuroSigma, Inc.
  • Nuraleve Inc.
  • Soterix Medical Inc
  • St. Jude Medical, Inc.
  • SUNY Downstate Medical Center
  • The University of Utah
  • University of California, Los Angeles
  • University of Central Florida
  • University of Illinois
  • University of Milan
  • University of Oxford
  • University of South Florida
  • Wedge Therapeutics

第6章 深部脳刺激装置 - 最近の動向

第7章 付録

図表

図表

List of Tables

List of Tables

  • Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
  • Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
  • Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
目次
Product Code: GDME1225EPD

GlobalData's Medical Devices sector report, "Deep Brain Stimulators (DBS) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Deep Brain Stimulators (DBS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A DBS is a device that is comprised of a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically-implanted electrodes to specific targets in the brain.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Deep Brain Stimulators (DBS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Deep Brain Stimulators (DBS) Overview

3 Products under Development

  • 3.1 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
  • 3.2 Deep Brain Stimulators (DBS) - Pipeline Products by Territory
  • 3.3 Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
  • 3.4 Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
  • 3.5 Deep Brain Stimulators (DBS) - Ongoing Clinical Trials

4 Deep Brain Stimulators (DBS) - Pipeline Products under Development by Companies

  • 4.1 Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
  • 4.2 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development

5 Deep Brain Stimulators (DBS) Companies and Product Overview

  • 5.1 Actipulse Neuroscience Inc Company Overview
    • 5.1.1 Actipulse Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Adaptive Neuromodulation GmbH Company Overview
    • 5.2.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Adept Neuro SA Company Overview
    • 5.3.1 Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Aleva Neurotherapeutics SA Company Overview
    • 5.4.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Allegheny Health Network Company Overview
    • 5.5.1 Allegheny Health Network Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Baylor College of Medicine Company Overview
    • 5.6.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Bioinduction Limited Company Overview
    • 5.7.1 Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Boston Scientific Corp Company Overview
    • 5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Brainsway Ltd Company Overview
    • 5.9.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 ClearPoint Medical Company Overview
    • 5.10.1 ClearPoint Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 ClearPoint Neuro Inc Company Overview
    • 5.11.1 ClearPoint Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Cleveland Medical Devices Inc Company Overview
    • 5.12.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Clinatec Company Overview
    • 5.13.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Deep Brain Innovations, LLC Company Overview
    • 5.14.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Enspire DBS Therapy Inc Company Overview
    • 5.15.1 Enspire DBS Therapy Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Fisher Wallace Laboratories, LLC Company Overview
    • 5.16.1 Fisher Wallace Laboratories, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Functional Neuromodulation Inc. Company Overview
    • 5.17.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Louisiana State University Company Overview
    • 5.18.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Massachusetts General Hospital Company Overview
    • 5.19.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Massachusetts Institute of Technology Company Overview
    • 5.20.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Medtronic Plc Company Overview
    • 5.21.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 National Cheng-Kung University Hospital Company Overview
    • 5.22.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 NeuroOne Inc Company Overview
    • 5.23.1 NeuroOne Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Neuroparticle Corp Company Overview
    • 5.24.1 Neuroparticle Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 NeuroPro Technologies Inc Company Overview
    • 5.25.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Neurosigma Inc Company Overview
    • 5.26.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Newronika s.r.l. Company Overview
    • 5.27.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Nexeon MedSystems Inc Company Overview
    • 5.28.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Nia Therapeutics Inc Company Overview
    • 5.29.1 Nia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.30.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 St. Jude Medical LLC Company Overview
    • 5.31.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Sunnybrook Health Sciences Centre Company Overview
    • 5.32.1 Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 SUNY Downstate Medical Center Company Overview
    • 5.33.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 University of California Los Angeles Company Overview
    • 5.34.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 University of California San Francisco Company Overview
    • 5.35.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 University of Central Florida Company Overview
    • 5.36.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 University of Florida Company Overview
    • 5.37.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 University of Houston Company Overview
    • 5.38.1 University of Houston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39 University of Illinois Company Overview
    • 5.39.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40 University of Milan Company Overview
    • 5.40.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41 University of Oxford Company Overview
    • 5.41.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42 University of Rochester Company Overview
    • 5.42.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43 University of South Florida Company Overview
    • 5.43.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44 Wedge Therapeutics Company Overview
    • 5.44.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview

6 Deep Brain Stimulators (DBS)- Recent Developments

  • 6.1 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
  • 6.2 Nov 03, 2021: BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021
  • 6.3 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
  • 6.4 Oct 12, 2021: BrainsWay Announces Prominent Addition to Scientific Advisory Board
  • 6.5 Sep 09, 2021: BrainsWay to Participate in Two Upcoming Investor Conferences
  • 6.6 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
  • 6.7 Jul 28, 2021: BrainsWay to Report Second Quarter 2021 Financial Results on August 11, 2021
  • 6.8 Jul 22, 2021: NeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021
  • 6.9 Jun 30, 2021: Wise Therapeutics and Soterix Medical jointly announce positive results of study combining Gamified Digital Therapeutics with neurostimulation device
  • 6.10 Jun 03, 2021: NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance
  • 6.11 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
  • 6.12 May 19, 2021: BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
  • 6.13 May 19, 2021: Avijit Ghosh named interim executive VP for U of I System
  • 6.14 Mar 08, 2021: BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference
  • 6.15 Feb 23, 2021: Will Weatherford elected vice chair of the USF Board of Trustees
  • 6.16 Feb 17, 2021: St. Petersburg Conference on World Affairs to provide global perspective and insight into historic turmoil
  • 6.17 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
  • 6.18 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
  • 6.19 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
  • 6.20 Nov 24, 2020: Griffith researchers develop long-term implantable electronics

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer